Stephen G. Davies
Affiliations: | Chemistry | University of Oxford, Oxford, United Kingdom |
Google:
"Stephen Davies"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Derek Harold Richard Barton | grad student | ||
| Hugh Felkin | grad student | ||
| Malcolm L.H. Green | grad student | Oxford University UK | |
| Gordon Harlow Whitham | grad student | 1975 | Oxford University UK |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| de la Camara CM, Storm T, Salman A, et al. (2023) Developmental Expression of the Cell Cycle Regulator p16 in Retinal Glial Cells: A Novel Marker for Immature Ocular Astrocytes? The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 221554231184286 |
| Josa-Culleré L, Galan SRG, Cogswell TJ, et al. (2023) Phenotypic screening identifies a trisubstituted imidazo[1,2-a]pyridine series that induces differentiation in multiple AML cell lines. European Journal of Medicinal Chemistry. 258: 115509 |
| Davies SG, Fletcher AM, Linsdall SM, et al. (2023) General Approach to Enantiopure 1-Aminopyrrolizidines: Application to the Asymmetric Synthesis of the Loline Alkaloids. The Journal of Organic Chemistry |
| Jackson TR, Vuorinen A, Josa-Culleré L, et al. (2022) A tubulin binding molecule drives differentiation of acute myeloid leukemia cells. Iscience. 25: 104787 |
| Balmforth D, Swales JA, Silpa L, et al. (2022) Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 155: 105248 |
| Chatzopoulou M, Conole D, Emer E, et al. (2022) Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy. Bioorganic & Medicinal Chemistry. 69: 116812 |
| Josa-Culleré L, Cogswell TJ, Georgiou I, et al. (2021) Identification and Preliminary Structure-Activity Relationship Studies of 1,5-Dihydrobenzo[][1,4]oxazepin-2(3)-ones That Induce Differentiation of Acute Myeloid Leukemia Cells In Vitro. Molecules (Basel, Switzerland). 26 |
| Josa-Culleré L, Madden KS, Cogswell TJ, et al. (2021) A Phenotypic Screen Identifies a Compound Series That Induces Differentiation of Acute Myeloid Leukemia Cells and Shows Antitumor Effects . Journal of Medicinal Chemistry. 64: 15608-15628 |
| Vuorinen A, Wilkinson IVL, Chatzopoulou M, et al. (2021) Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy. European Journal of Medicinal Chemistry. 220: 113431 |
| Chatzopoulou M, Emer E, Lecci C, et al. (2020) Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators. Acs Medicinal Chemistry Letters. 11: 2421-2427 |